2m 2m 2m 2m 2m 2m 2m
ELICIO THERAPTCS (ELTX)
NASDAQ
$12.47-$0.06 (-0.48%)
Price as of Jun 03, 2026 4:31 PM EDT- $218.3MMarket Cap
- 54.69%1-Year Change
- BiotechnologyIndustry
ELICIO THERAPTCS (ELTX)
$12.47-$0.06 (-0.48%)
ELTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $12.53 | ||
Change | +$1.04 (+9.05%) | ||
Open | $11.46 | ||
High | $12.70 | ||
Low | $11.06 | ||
Previous Close | $11.49 | ||
Volume | 150,442 | ||
30-Day Average Volume | 136,805 | ||
1-Week Change | 16.34% | ||
1-Month Change | 16.56% | ||
1-Year Change | 54.69% | ||
3-Year Change | -30.95% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 19.1M | ||
Total Assets | $22.7M | ||
Market Cap | $218.3M | ||
Enterprise Value | $212.9M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$11.8M | ||
Free Cash Flow | -$11.6M | ||
EBIT | -$11.8M | ||
EBITDA | -$11.8M | ||
Net Working Capital | $9.0M | ||
EPS | -$0.65 | ||
Enterprise Value/EBITDA | -18 | ||
Enterprise Value/Revenue | N/A | ||
P/B | -152 | ||
P/E | -18 | ||
PEG | 1 | ||
Price/Free Cash Flow | -19 | ||
Price/Operating Cash Flow | -19 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue